X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home IPR Data Management

TraceLink Introduces New Agile Issue Management Solution

Content Team by Content Team
3rd June 2020
in IPR Data Management, News
TraceLink Introduces New Agile Issue Management Solution

TraceLink Inc. unveiled Agile Issue Management, a network-based supply chain solution that enables companies to collaboratively identify, document and resolve disruptive supply chain issues to ensure the availability of critical medicines and healthcare products for commercial partners and patients.

Agile Issue Management is a collaboration platform that connects internal stakeholders to their network of external trading partners to quickly identify issues and respond to disruptions in their supply chains. By leveraging one common platform, supply chain partners can coordinate their response to issues and disruptions, greatly improving the effectiveness of the resolution process while reducing the cost of valuable personnel time. This is an important first step in building supply chain agility and resilience.

“Unplanned events and disruptions have become our ‘next normal’. Today’s process for managing supply chain issues – emails, faxes, phone calls and spreadsheets – is no longer sufficient,” said Shabbir Dahod, president and CEO, TraceLink. “By reacting immediately to issues in a structured and organized way, supply chain networks have the power to drive immediate value. We’ve seen this power first-hand, with some of our early adopters reducing manufacturing disruptions by over 90 percent and generating more than $100 million in annual cost savings.”

Key Capabilities of Agile Issue Management Include:

  • Resolve Issues Faster. Every issue is identified, logged and accountability assigned to ensure the right people are aware and respond immediately.
  • Reduce Supply Chain Disruptions. Partners across the supply chain can identify and resolve issues early, before they become operational disruptions. Additionally, the root cause analysis capabilities allow for early detection of systemic problems, preventing issues from reoccurring.
  • Gain Visibility and Control. Leaders can use dashboards to proactively follow issues, track operational incidents, and monitor the progress of issue resolution.
  • Collaborate on Change Requests and Quality Documentation. Managing change requests and quality release documentation is done in one integrated place.

Previous Post

AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors

Next Post

Greenphire Launches New Clinical Trial Budget Build and Negotiation Solution, EnvisiX

Related Posts

SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Stringent Policy around COVID Vaccines Laid by FDA
FDA Approvals

Stringent Policy around COVID Vaccines Laid by FDA

29th May 2025
Drugmakers Asked to Strictly Follow the US Pricing Reforms
Manufacturing

Drugmakers Asked to Strictly Follow the US Pricing Reforms

28th May 2025
DHL Supply Chain
News

DHL Supply Chain comes up with New Pharma Hub in Singapore

19th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Drug Development

Advanced Instruments All Set To Merge With Nova Biomedical

22nd March 2025
Next Post
Greenphire Launches New Clinical Trial Budget Build and Negotiation Solution, EnvisiX

Greenphire Launches New Clinical Trial Budget Build and Negotiation Solution, EnvisiX

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In